Supplementary Figure 6 from Synergistic Antitumor Activity of Cetuximab and Namitecan in Human Squamous Cell Carcinoma Models Relies on Cooperative Inhibition of EGFR Expression and Depends on High <i>EGFR</i> Gene Copy Number

<p>PDF file - 75K, Effect of p38 inhibition on cell proliferation of A431 cells exposed to cetuximab alone (0.5microg/ml) or plus namitecan (0.01microM) for 72 h.</p>